2016
DOI: 10.18632/oncotarget.8965
|View full text |Cite
|
Sign up to set email alerts
|

Asclepiasterol, a novel C21 steroidal glycoside derived fromAsclepias curassavica, reverses tumor multidrug resistance by down-regulating P-glycoprotein expression

Abstract: Multidrug resistance (MDR) mediated by P-glycoprotein (P-gp) is a major cause of cancer therapy failure. In this study, we identified a novel C21 steroidal glycoside, asclepiasterol, capable of reversing P-gp-mediated MDR. Asclepiasterol (2.5 and 5.0μM) enhanced the cytotoxity of P-gp substrate anticancer drugs in MCF-7/ADR and HepG-2/ADM cells. MDR cells were more responsive to paclitaxel in the presence of asclepiasterol, and colony formation of MDR cells was only reduced upon treatment with a combination of… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
17
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 27 publications
(18 citation statements)
references
References 60 publications
(57 reference statements)
1
17
0
Order By: Relevance
“…We further uncovered that US could increase ROS activity, but could not significantly decrease P-gp expression in these cells. Our results are similar to previous studies showing targeting P-gp was less effective in treating MCF-7 cells than that in treating MCF-7/ADR cells [ 55 , 56 ]. These probably result from the rather low baseline level of P-gp expression in drug-sensitive cells, which decreases the silence efficiency [ 56 ].…”
Section: Discussionsupporting
confidence: 92%
“…We further uncovered that US could increase ROS activity, but could not significantly decrease P-gp expression in these cells. Our results are similar to previous studies showing targeting P-gp was less effective in treating MCF-7 cells than that in treating MCF-7/ADR cells [ 55 , 56 ]. These probably result from the rather low baseline level of P-gp expression in drug-sensitive cells, which decreases the silence efficiency [ 56 ].…”
Section: Discussionsupporting
confidence: 92%
“…However, little is known concerning the effects of TRIB2 gene knockdown on drug-resistant proteins. Previous studies have found that the downregulation of drug-resistance proteins may partly depend on inhibition of the ERK pathway in cancer (11)(12)(13). In the present study, we explored changes in the ERK signaling pathway after knockdown of the TRIB2 gene in K562/ADM cells.…”
Section: Introductionmentioning
confidence: 92%
“…6) ABCB1 is a target of the Ras/Raf signaling pathway, suppression of p38, ERK or JNK pathways enhanced sensitivity to chemotherapeutic drugs in multidrug resistant tumor cells. [7][8][9][10] Paris polyphylla var. yunnanensis (Franch.)…”
Section: Introductionmentioning
confidence: 99%